’s Broadfin Capital has revealed a new stake in
Retrophin Inc (NASDAQ:RTRX
), which amasses 6.93% of the company’s common stock, it contains 1.61 million shares.
RTRX) is a pharmaceutical company that develops, acquires and commercializes drugs for the treatment of serious, catastrophic or rare diseases.
A week back, Retrophin conducted an underwritten public offering of 4.71 million shares at a price of $8.50 per share. Following the offering, the company got approved to list its common stock on the NASDAQ market, moving it from the previous OTCQB.
The gross proceeds from the offering, which amount to around $40 million, will be used to obtain regulatory approval for the reintroduction of Syntocinon into the U.S. market
, the company said in a statement
also holds several other drug candidates on different development stages, so the rest of the proceeds are planned to be used to support its research programms
Also, recently Retrophin Inc (NASDAQ:
RTRX) acquired privately-held Kyalin
Biosciences, Inc., a company that develops therapies which targets the core symptoms of autism.
In this way, since the stock has been transferred on to
the NASDAQ market, we can expect that investors will become more interested in the company. The stock already gained over 80% since January 2.
, the Chief Executive Officer and founder of Retrophin Inc (NASDAQ:
RTRX), purchased 8,000 shares of the company earlier this week, raising his stake to 2.83 million shares.
The latest moves made by Broadfin Capital, is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL
), where the fund boosted
its stake to 4.5 million shares, from some 3.6 million. The fund also upped
its stake in Derma Sciences Inc (NASDAQ:DSCI
) to 871,600 shares, up from 771,600 shares. The fund also added
Biodel Inc (NASDAQ:BIOD
) to its equity portfolio, and currently holds a stake of 5.2% in the company.
Millenium Management Continues Selling Liberator Medical Holdings Inc (LBMH) Stock
Ken Griffin Boosts Stake in Affymetrix, Inc. (AFFX); Cuts Penn Virginia Corporation (PVA)
Mason Capital Management Boosts Stake in Hubbell Incorporated (HUB.A)